Endotherapeutics
Print

Macroplastique for SUI

Macroplastique is an injectable soft-tissue bulking agent used to treat stress urinary incontinence (SUI) primarily due to intrinsic sphincter deficiency (ISD).

Predictable Procedure

  • Unique delivery system ensures precise implantation
  • May be performed in the office
  • Permanent implants: non-degradable, non-resorbable
  • Soft, flexible, textured implant particles create an excellent matrix for collagen deposition
  • Histological examination of tissue explants revealed no evidence of particle migration

Proven Performance

In a multi-center clinical study*, Macroplastique demonstrated excellent clinical efficacy

  • 122 patients received Macroplastique and were followed for 12 months from initial treatment
  • 75 of 122 (61.5%) were improved at 12 months based on Stamey grade
  • 45 of 122 (36.8%) were dry based on Stamey grade

No serious treatment-related adverse events were associated with Macroplastique procedures
Twenty-four month follow-up data were available on 84 Macroplastique subjects. Of these 84 subjects, 63 had improvement in Stamey Grade at 24 months, 28 of whom were dry.

Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: Results of a multicenter, randomised, controlled, single-blind study¹

For further information about Macroplastique or to arrange a visit by one of our product specialists, please contact us here.

 

Reference Material

References

1. Ghoniem, G. et al. (2009). J Urol. 181, 204-210.